What Causes Restless Legs with Adenomyosis?

What Causes Restless Legs with Adenomyosis?

Yes — adenomyosis can directly trigger restless legs syndrome (RLS), primarily through iron depletion from heavy menstrual bleeding and through estrogen-driven dopamine dysregulation. The main caveat: RLS severity tracks closely with ferritin levels, so women who have managed blood loss well may not experience it. The clearest exception is the subset whose RLS worsens in the luteal phase regardless of iron status, pointing to a hormonal mechanism independent of iron.

---

Why Adenomyosis Sets the Stage for Restless Legs

Adenomyosis is a condition in which endometrial-like tissue embeds within the myometrium, the muscular wall of the uterus. The result is a heavier, more prolonged menstrual cycle that can extract 80–200 mL of blood per period — two to five times the typical 30–40 mL loss (Munro et al., Fertility and Sterility 2011; PMID: 21345435). Chronic blood loss of that magnitude steadily depletes iron stores. Ferritin — the body's primary iron storage protein — can fall into the 10–20 ng/mL range long before hemoglobin drops enough to register as clinical anemia on a standard CBC.

This matters enormously for RLS because iron is a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. When brain iron is low, dopaminergic signaling in the basal ganglia and spinal cord falters, producing the characteristic urge to move, the creeping or crawling sensations, and the circadian worsening that defines RLS (Allen et al., Sleep Medicine 2013; PMID: 23246278). The link is tight enough that the International Restless Legs Syndrome Study Group now recommends checking serum ferritin in every newly diagnosed RLS patient, with an intervention threshold of ferritin < 75 ng/mL.

So the first causal pathway looks like this:

1. Adenomyosis → heavy menstrual bleeding
2. Heavy bleeding → chronic iron depletion
3. Low iron → impaired dopamine synthesis
4. Dopamine deficit → RLS symptoms, worst at night

If you are experiencing other debilitating symptoms alongside this, it is worth reading about what causes exhaustion with adenomyosis, since the same iron-depletion pathway drives both complaints simultaneously.

---

Estrogen, Dopamine, and the Hormonal Dimension

The iron story explains a lot, but not everything. Many women with adenomyosis report that their RLS spikes in the days just before menstruation even when their ferritin has been corrected. That pattern implicates estrogen and progesterone fluctuations directly.

Estrogen acutely upregulates dopamine receptor sensitivity. As estrogen rises in the follicular phase, dopaminergic tone improves and RLS symptoms often ease. When estrogen drops sharply in the late luteal phase, dopamine signaling dips again, and RLS re-emerges. In women with adenomyosis, this hormonal swing is exaggerated because the ectopic tissue itself produces aromatase, the enzyme that converts androgens to estrogen, sustaining a state of localized estrogen excess (Bulun et al., Endocrine Reviews 2012; PMID: 22240242). The subsequent crash before menstruation is therefore steeper than average, producing a pronounced dopamine withdrawal effect in susceptible women.

Estrogen also modulates iron metabolism through hepcidin suppression. Higher estrogen keeps hepcidin low, which increases intestinal iron absorption — but this benefit evaporates in the late luteal phase, adding a second mechanism that compounds the dopamine problem at the worst possible time in the cycle.

---

Systemic Inflammation as an Amplifier

Adenomyosis is not merely a structural problem; it is an inflammatory disease. Affected tissue secretes elevated levels of prostaglandins, interleukin-1β, interleukin-6, and tumor necrosis factor-alpha (Bourdon et al., Human Reproduction Update 2021; PMID: 33528530). These cytokines create systemic inflammation that reaches the central nervous system.

Chronic inflammation interferes with RLS through two routes:

• Hepcidin induction: Inflammatory cytokines, especially IL-6, sharply raise hepcidin, which blocks ferroportin-mediated iron export from enterocytes and macrophages. The result is functional iron deficiency even when total body iron stores appear adequate — a pattern called anemia of chronic disease or anemia of inflammation. Ferritin can look normal or even elevated while tissue iron remains insufficient.
• Neuroinflammation: Elevated cytokines cross the blood-brain barrier and disrupt dopaminergic pathways in the substantia nigra and striatum, independent of iron status entirely.

This inflammatory amplifier explains why some women see RLS persist after successful iron repletion, and why addressing inflammation as its own target matters.

Women with adenomyosis often carry a broader cluster of neurological and sensory symptoms driven by this same inflammatory environment. The overlap between migraines with adenomyosis and restless legs is not coincidental — both reflect central sensitization fueled by the same cytokine burden.

---

Key Biomarkers to Evaluate

If you suspect your RLS is adenomyosis-related, the following panel gives the clearest picture:

A standard CBC alone is insufficient. Hemoglobin can remain in the normal range while ferritin sits at 12 ng/mL — a value clearly associated with RLS onset in population studies.

---

Magnesium's Separate Role

Beyond iron, magnesium deficiency is a clinically recognized, independent contributor to RLS. Magnesium regulates NMDA receptor activity in the spinal cord; insufficient magnesium allows excitatory glutamate signaling to run unchecked, producing the involuntary leg movements and nocturnal dysesthesia characteristic of RLS (Hornyak et al., Sleep 1998; PMID: 9703590).

Women with adenomyosis are at higher-than-average risk of magnesium depletion for two reasons: chronic inflammation impairs magnesium retention at the renal level, and heavy bleeding removes magnesium bound within red blood cells. Dietary surveys consistently show that 50–60% of American women already fall below the RDA of 310–320 mg/day, so the starting point is often already low before adenomyosis compounds it.

Checking RBC magnesium (not serum magnesium, which is a poor functional marker) is the most informative test. A value below 5.2 mg/dL in the context of active RLS symptoms is a clear indication for supplementation.

The same magnesium gap that worsens restless legs also contributes to what causes headaches before your period with adenomyosis, since magnesium is a well-established migraine prophylactic — making repletion doubly relevant for women with both symptom clusters.

---

Vitamin D and the Neurological Connection

Vitamin D deficiency correlates with increased RLS severity in observational data, and the proposed mechanism involves vitamin D's role in dopamine synthesis and neurotrophic signaling. A 2014 cross-sectional study found that RLS patients had significantly lower serum 25-OH vitamin D levels than matched controls (Wali et al., Sleep Medicine 2015; PMID: 25600781). Adenomyosis is itself associated with lower vitamin D levels, partly through inflammatory consumption of 25-OH vitamin D and partly through the indoor, sedentary behavior that severe pelvic pain encourages.

This does not mean vitamin D supplementation alone resolves RLS — it does not. But restoring 25-OH vitamin D to the 40–60 ng/mL range removes a modifiable neurological stressor and supports the overall dopaminergic environment in which iron and magnesium can work more effectively.

---

What This Means for Your Formula

Addressing RLS in the context of adenomyosis requires a layered approach: correct the iron deficit, dampen inflammation, stabilize magnesium, and support the nervous system's overall signaling environment. Ones builds personalized capsule formulas that account for exactly this kind of multi-driver picture, pulling in relevant actives based on lab values, symptom history, and hormonal context.

Three ingredients that are particularly relevant for this symptom cluster:

Magnesium Complex (Ones proprietary blend): Ones includes a Magnesium Complex blend calibrated to deliver magnesium glycinate-equivalent bioavailability — a form that crosses the blood-brain barrier more efficiently than magnesium oxide and has been shown to reduce nocturnal leg cramping and RLS symptom severity in small randomized trials. The dose targets the 300–400 mg elemental range, which matches what the clinical literature supports.

Vitamin D3 + K2 (MK-7): Ones pairs D3 with MK-7 to support both neurological vitamin D signaling and to direct calcium appropriately. Given the double association between low D3 and adenomyosis severity and RLS severity, this pairing addresses two converging pathways with one ingredient slot.

Adrenal Support (Ones System Blend): Chronic pain and disrupted sleep from RLS dysregulate the HPA axis, elevating cortisol and worsening the inflammatory burden that perpetuates the cycle. Ones' Adrenal Support blend is designed to modulate cortisol reactivity — an indirect but meaningful lever for reducing the systemic inflammation that amplifies both RLS and adenomyosis pain.

For women whose lab work shows ferritin below 50 ng/mL, Ones' AI practitioner flags this gap explicitly and incorporates iron-adjacent recommendations (such as noting when a dedicated iron supplement should be added through a prescribing provider, since therapeutic iron is typically a prescription or medical-grade decision based on GI tolerance).

RLS is one node in a broader web of adenomyosis-associated neurological and connective-tissue symptoms. If restless legs coexist with hair thinning with adenomyosis or brittle nails with adenomyosis, the shared root is almost always iron depletion and inflammatory cytokine excess — the same drivers that Ones' analysis is structured to identify.

---

Practical Protocol Summary

For a clinician or informed patient working through this systematically:

1. Order the biomarker panel above — prioritize ferritin, RBC magnesium, hs-CRP, and 25-OH vitamin D.
2. Address ferritin first — work with your gynecologist or hematologist if ferritin is < 50 ng/mL; oral iron with vitamin C away from coffee/tea, or IV iron if GI intolerance is a barrier.
3. Replicate magnesium to 300–400 mg elemental daily — use glycinate or malate forms, taken in the evening, as evening dosing provides the greatest nocturnal benefit.
4. Restore 25-OH vitamin D to 40–60 ng/mL — typical loading at 2,000–5,000 IU D3 daily with K2 co-administration; retest at 12 weeks.
5. Target inflammation at the source — discuss hormonal management of adenomyosis (progestins, GnRH agonists, or surgical options) with your specialist; systemic inflammation will not fully resolve while the underlying disease remains active.
6. Track cycle-phase RLS patterns — a simple symptom diary matched to your cycle day helps confirm whether the luteal-phase hormonal mechanism is dominant and guides whether hormonal interventions are likely to be the highest-yield next step.

---

Key Takeaways

• Adenomyosis drives restless legs primarily through chronic iron depletion (from heavy bleeding), estrogen-mediated dopamine instability, and systemic inflammation — three separate but interacting pathways.
• Ferritin below 75 ng/mL is the most actionable lab finding; hemoglobin can remain normal while ferritin is severely depleted, so a standard CBC misses this.
• RLS that worsens specifically in the luteal phase, even with adequate ferritin, points to the estrogen-dopamine mechanism and may respond better to hormonal management of the underlying adenomyosis than to iron alone.
• Inflammatory cytokines (IL-6, TNF-α) induce hepcidin, which blocks iron absorption and causes functional iron deficiency even when ferritin appears borderline normal — making inflammation control a prerequisite for effective iron repletion.
• Magnesium and vitamin D are independent modifiers of RLS severity and are both commonly depleted in women with adenomyosis; RBC magnesium and 25-OH vitamin D testing are underutilized but high-yield.
• A personalized approach — one that maps your specific biomarker gaps to targeted ingredients at clinical doses — is more likely to resolve RLS than a one-size-fits-all supplement stack.

---

This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before changing your supplement regimen or if you are experiencing significant symptoms.